newsfilter
← Latest News
FDA Approved Drugs·

Approval of Livdelzi, Nda #217899 (Type 1 - New Molecular Entity)

Approval Date: 08/14/2024; Drug Name: Livdelzi, Nda #217899; Active Ingredients: SELADELPAR; Company: Cymabay Therapeutics Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 217899

Company
CYMABAY THERAPEUTICS INC
Keywords
CYMABAY THERAPEUTICS INC